I. Siegle et al., Cellular localization and regional distribution of CYP2D6 mRNA and proteinexpression in human brain, PHARMACOGEN, 11(3), 2001, pp. 237-245
The cytochrome P4502D6 (CYP2D6) is involved in the biotransformation of man
y drugs which predominantly act in the central nervous system (CNS), includ
ing opioids, various psychotrophic drugs and neurotoxins, Until now, howeve
r, only controversial information is available regarding the presence of CY
P2D6 in CNS, In this study, the regional and cellular expression of CYP2D6
transcripts and proteins in postmortem brain tissues of three individuals w
as analysed, A combination of in-situ hybridization coupled with immunohist
ochemistry on adjacent sections allowed simultaneous detection of CYP2D6 mR
NA and protein, However, discrepancies existed in the results such that the
mRNA was more widely distributed in the brain areas analysed compared to t
he protein, Neuronal cells, as well as glial cells, showed labelling for mR
NA in brain regions such as the neocortex, caudate nucleus, putamen, globus
pallidus, hippocampus, hypothalamus, thalamus, substantia nigra and cerebe
llum, In contrast, CYP2D6 protein was primarily localized in large principa
l neurons such as pyramidal cells of the cortex, pyramidal cells of the hip
pocampus, and Purkinje cells of the cerebellum, In glial cells, CYP2D6 prot
ein was absent, These results provide clear evidence of CYP2D6 expression i
n certain regions of the CNS and may indicate the role CYP2D6 plays in a nu
mber of drug interactions that are of potential clinical importance for neu
rological diseases, Pharmacogenetics 11:237-245 (C) 2001 Lippincott William
s & Wilkins.